Among the least characterized herpesvirus membrane proteins are the homologs of UL43 of herpes simplex virus 1 (HSV-1). To identify and characterize the UL43 protein of pseudorabies virus (PrV), part of the open reading frame was expressed in Escherichia coli and used for immunization of a rabbit. The antiserum recognized in Western blots a 34-kDa protein in lysates of PrV infected cells and purified virions, demonstrating that the UL43 protein is a virion component. In indirect immunofluorescence analysis, the antiserum labeled vesicular structures in PrV infected cells which also contained glycoprotein B. To functionally analyze UL43, a deletion mutant was constructed lacking amino acids 23-332 of the 373aa protein. This mutant was only slightly impaired in replication as assayed by one-step growth kinetics, measurement of plaque sizes, and electron microscopy. Interestingly, the PrV UL43 protein was able to inhibit fusion induced by PrV glycoproteins in a transient expression-fusion assay to a similar extent as gM. Double mutant viruses lacking, in addition to UL43, the multiply membrane spanning glycoproteins K or M did not show a phenotype beyond that observed in the gK and gM single deletion mutants. D
Introduction
Herpesvirus envelope proteins play essential roles in the initial stages of virus infection, i.e., virion attachment and penetration (Spear and Longnecker, 2003) . However, they are also important in mediating proper assembly and egress of virus particles in the late phase of the replicative cycle (Mettenleiter, 2002 (Mettenleiter, , 2004 . In the alphaherpesviruses, more than 10 glycosylated virus-encoded proteins are part of the virion envelope. Besides these glycoproteins, several nonglycosylated membrane-associated proteins are also part of the virion.
Among the least characterized membrane proteins is the product of the UL43 gene of HSV-1 and its homologues. The UL43 gene and gene products are conserved only within the Alpha-and Gammaherpesvirinae subfamilies but are absent from the Betaherpesvirinae (Davison, personal communication) . The UL43 protein of HSV-1 has been identified by epitope-tagging as a 30-kDa polypeptide (Carter et al., 1996) which is substantially smaller than the ca. 40-kDa protein predicted from the open reading frame. The HSV-1 UL43 mRNA is transcribed with early kinetics (Carter et al., 1996) as is the PrV UL43 message (de Wind et al., 1994; Powers et al., 1994) . Interestingly, an open reading frame that maps antisense to the UL43 gene, designated as UL43.5, has been identified in HSV-1 which is regulated with late kinetics, and encodes a nuclear protein . The UL43 homologous protein in Epstein-Barr-Virus (EBV), the product of the BMRF2 gene, is a 53-to 55-kDa virion polypeptide which is associated with intracellular membranes (Johannsen et al., 2004; Modrow et al., 1992; Tugizov et al., 2003) .
The UL43 gene products possess several possible transmembrane domains with a hydrophilic loop in the middle of the protein and an N-terminal hydrophilic extension (Fig.  1A) . Studies on the homologous BMRF2 protein of EBV indicated that it may be located in the virion envelope playing a role in infection of polarized epithelial cells by interaction of an RGD motif with cellular integrins (Tugizov et al., 2003) . However, neither the PrV nor the HSV-1 homolog contain this motif and deletion of UL43 in HSV-1 did not impair viral replication either in cell culture or in a mouse infection model, including no effect on neuroinvasion and transneuronal spread (MacLean et al., 1991) . In PrV, UL43 has also been shown to be non-essential for virus growth in cell culture (Powers et al., 1994) , although no animal studies have yet been performed with the PrV mutant.
In our systematic analysis of virion components of PrV, we aimed at identification and characterization of the UL43 protein. To this end, we obtained an antiserum against the PrV UL43 protein which was used to identify the PrV UL43 protein as a component of extracellular virions. Intracellularly, the PrV UL43 protein resides in intracytoplasmic vesicles colocalizing with glycoprotein B. We further demonstrate that like the multiply membrane spanning glycoprotein M, the PrV UL43 protein exhibits fusioninhibitory activity which may indicate similar functions of these two virion envelope proteins during virus replication.
Results

Identification of the PrV UL43 protein
A monospecific polyclonal rabbit antiserum was prepared against a bacterially expressed GST fusion protein containing amino acids (aa) 147-231 of the deduced PrV UL43 protein. These amino acids are located in a predicted hydrophilic loop (Fig. 1A ) of the otherwise highly hydrophobic polypeptide. In purified PrV-Ka virions (Fig. 2, right Fig. 1 . Predicted secondary structure of the PrV UL43 protein and construction of UL43 mutant virus. (A) Secondary structure of the deduced UL43 protein is shown as predicted by the program SOSUI (http://sosui.proteome.bio.tuat.ac.jp; Hirokawa et al., 1998) . Amino acids of UL43 contained in the GST fusion protein for rabbit immunization are indicated in dark grey. Putative transmembrane domains are boxed. (B) The PrV genome consists of long and short unique regions (U L , U S ), and inverted repeat sequences (IR, TR) flanking the U S region. The location of BamHI restriction fragments is indicated. In a magnification of the genome region containing the UL43 gene polyadenylation signals for the UL43 and the upstream UL42 gene are indicated. For construction of a UL43 deletion mutant, a XhoI fragment was deleted from the open reading frame. panels) as well as in PrV-Ka infected cells (Fig. 2 , left panels), the antiserum recognized a ca. 34-kDa protein which is somewhat smaller than the predicted molecular mass for the PrV UL43 gene product of 38 kDa. For control, parallel blots were probed with antibodies against virion glycoproteins gM, gK, gB, gC, and gH, as well as against tegument protein UL37. Purity of the virus preparation was ascertained by electron microscopy (data not shown) and by lack of reactivity with an antiserum directed against the primary envelope protein UL34 (Klupp et al., 2000b) . Thus, we identified for the first time the PrV UL43 protein and demonstrated that it is indeed a virion component. In infected and mock-infected cells, a cellular protein which migrates slightly faster than the UL43 protein was non-specifically recognized by the antiserum.
Intracellular localization of the PrV UL43 protein
Using our monospecific antiserum in immunofluorescence analyses of PrV-Ka infected cells, prominent immunostaining was observed in intracellular vesicular structures ( PrV-DgKw, PrV-DUL43/Mg, PrV-DgK/UL43G, or mock-infected cells were separated by electrophoresis in SDS-polyacrylamide gels. After transfer to nitrocellulose or PVDF membranes, blots were probed with monospecific sera against UL43, gM, gK, UL37, UL34, or gH, or with monoclonal antibodies against gB and gC. Location of molecular mass markers is indicated on the left of each panel. and cells infected with a UL43 deletion mutant ( Fig. 3C , see below). This punctate intracytoplasmic staining was reminiscent of the labeling seen with anti-gB antibodies (Nixdorf et al., 2000 (Nixdorf et al., , 2001 . Therefore, infected cells were also analyzed by double-labeling experiments using the anti-UL43 serum ( Fig. 3D) and an anti-gB monoclonal antibody ( Fig. 3E ). It is evident that both, at least partly, colocalize in infected cells indicating that these vesicles contain the UL43 protein as well as gB ( Fig. 3F ).
To analyze whether this intracytoplasmic localization also occurs in the absence of other viral gene products, cells were transfected with expression plasmids for either UL43, or gB, or both, and analyzed. As shown in Fig. 3 , when expressed singly (Figs. 3G and H) or in combination (Figs. 3J-L), UL43 and gB also partly (co)localized within these vesicles. In contrast, gC was found primarily at the plasma membrane ( Fig. 3I ). Membrane localization of the UL43 protein was also observed (Fig. 3G ).
Isolation and characterization of a PrV UL43 deletion mutant
For further detailed analysis, we isolated PrV-DUL43, a UL43 deletion mutant that lacked codons 23-332 of the 373 amino acid UL43 protein ( Fig. 1B ). As shown in Fig. 2 , no UL43 gene product was detectable in either PrV-DUL43 virions or PrV-DUL43 infected cells, although, compared to PrV-Ka, controls showed a similar amount of viral proteins gM, gK, UL37, gB, gC, and gH. This verified the specificity of the antiserum and the lack of UL43 expression in the deletion mutant.
Neither the HSV-1 nor the PrV UL43 protein is required for viral replication in cell culture (MacLean et al., 1991; Powers et al., 1994) . This correlates with our findings that plaque size ( Fig. 4 ) and one-step growth kinetics ( Fig. 5 ) of PrV-DUL43 are only marginally impaired compared to PrV-Ka. Plaque size is reduced by approximately 10% and viral titers are decreased by ca. 2-to 5-fold. These defects were Fig. 4 . Plaque size of mutant viruses on non-complementing and complementing cells. RK13, RK13-UL43, RK13-gM, or RK13-gK cells were infected with the indicated viruses under plaque assay conditions. Plaques were measured microscopically 2 days pi. Relative plaque sizes were calculated and compared to those of PrV-Ka which were set as 100%. Average values and standard deviation of at least two independent experiments are shown. corrected on complementing UL43-expressing cells indicating that, although slight, they are indeed due to the UL43 deletion. Correlating with these results, in ultrastructural analyses PrV-DUL43 infected non-complementing cells showed all stages of virion formation (data not shown).
PrV UL43 protein inhibits fusion in an in vitro assay
We previously established an in vitro fusion assay using PrV glycoproteins gB-008 and gDH (Klupp et al., 2000a) . In this assay, we detected strong fusion inhibiting activity of the multiply membrane spanning envelope glycoprotein gM of PrV, or the gM/gN complex of equine herpesvirus 1 and infectious laryngotracheitis virus (Klupp et al., 2000a) . To test for a similar activity of the PrV UL43 protein, expression plasmids for gB-008 and gDH were cotransfected either with or without addition of expression plasmids encoding gM, gN, gM and gN, UL43, gK, UL20, or gK and UL20 (Dietz et al., 2000) . As shown in Fig. 6 , inclusion of the UL43 expression plasmid decreased fusion efficiency by ca. 80%, i.e., to a similar extent as a gM expression plasmid. In contrast, the multiply membrane spanning proteins gK and UL20 did not impair fusion when cotransfected singly with the fusion proteins. However, cotransfection of both gK and UL20 decreased fusion by ca. 70% which is in line with our previous observation that proper intracellular processing of PrV gK requires coexpression of the UL20 gene product (Dietz et al., 2000) .
Characterization of PrV double mutants in multiply membrane spanning envelope proteins
Since the UL43 protein, gM, and gK/UL20 inhibited fusion in an in vitro assay, there could be functional redundancy between these proteins. To test for this in the viral background, we constructed and analyzed double mutants lacking UL43 and either gM or gK. As shown in Fig. 2 , in PrV-DgK/UL43G infected non-complementing cells the UL43 and gK proteins were absent, but other viral envelope constituents such as gB, gC, gH, gM, and UL37 were present in amounts comparable to wild-type PrV Ka. A similar result was obtained when purified virions were analyzed (Fig. 2) . In PrV-DUL43/Mh infected cells the UL43 and gM proteins were missing but gB, gC, gH, gK, and UL37 were expressed and were also present in purified virions (Fig. 2) .
Deletion of gM alone only moderately impaired plaque formation of PrV and additional deletion of UL43 did not further decrease plaque size (Fig. 4) . In the absence of gK, plaque formation of PrV was drastically impaired (Dietz et al., 2000; Klupp et al., 1998) , no matter whether UL43 was present or absent. Plaque formation of gM-deleted viruses was enhanced on RK13-gMw cells, and plaque formation of gK-deleted viruses was fully restored on RK13-gK cells again without apparent involvement of UL43.
In one-step growth analyses (Fig. 5 ) similar results were obtained. On non-complementing cells PrV-DgK/43G produced titers similar to PrV-DgK indicating that the additional deletion of UL43 had no augmenting effect on the gK defect. On RK13-gKw cells, PrV-DgK/43G replicated to slightly lower titers than PrV-Ka, which reflects the slight growth defect attributable to the absence of UL43. A similar result was obtained with PrV-DUL43/Mh. Ultrastructural analyses confirmed these findings (data not shown). Thus, the additional deletion of UL43 had no effect on the replication of gK-or gM-deleted virus mutants.
Discussion
The UL43 protein which is conserved in alpha-and gammaherpesviruses but absent in betaherpesviruses (Baer et al., 1984; Chee et al., 1990; McGeoch et al., 1988) is one of the least characterized of the alphaherpesvirus gene products which have been proven or predicted to be transmembrane proteins. Although the genomic sequence of the respective PrV protein has been known for some time (Powers et al., 1994) , no gene product has so far been identified. Using a monospecific antiserum prepared against a predicted hydrophilic loop which separates two clusters of five and four predicted hydrophobic transmembrane regions (Fig. 1) , we identified the PrV UL43 protein as a 34-kDa protein which is present in infected cells and purified virions. This is the third identification of a UL43 protein after the homologous HSV-1 (Carter et al., 1996) and EBV proteins (Modrow et al., 1992) and is the first description of a UL43 protein as a constituent of alphaherpes virions. Our finding thus adds to the complexity of the alphaherpesvirus envelope. It is likely that the HSV-1 homolog of the PrV UL43 protein is also present in the virion as has been shown for the homologous EBV protein BMRF 2 (Johannsen et al., 2004) . Fig. 6 . Fusion assay. Expression plasmids for the fusion inducing gB-008 and gDH proteins of PrV were cotransfected with empty pcDNA3 control and expression plasmids for gM, gN, UL43, gK, and UL20 or with pairs of expression plasmids for gM and gN, or gK and UL20. Fusion was quantitated as described in Materials and methods. Average values and standard deviations of three independent experiments are shown.
Detailed analysis of a UL43 deletion mutant confirmed previous findings that the UL43 gene is not required for virus growth in cell culture (MacLean et al., 1991; Powers et al., 1994) . Viral titers were only ca. 2-to 5-fold lower than those of the isogenic wild-type PrV-Ka, and plaque size was also only marginally reduced. However, these slight defects were due to absence of UL43 and not to fortuitous other alterations in the viral genome since they could be corrected on UL43 expressing cells. Thus, absence of the UL43 protein is not without any effect on viral replication. In EBV, it has been suggested that the BMRF 2 protein is involved in attachment and entry into polarized epithelial tongue and nasopharyngeal cells by binding to cellular integrin (Tugizov et al., 2003) . In contrast, deletion of the HSV-1 UL43 protein had no effect in a mouse infection model (MacLean et al., 1991) , arguing against an important role of UL43 for in vivo infection. However, studies in a natural virus-host system using appropriate deletion and rescue mutants have not yet been performed.
In HSV-1, an open reading frame antisense to UL43, designated as UL43.5, has been detected which expresses a protein that colocalizes with capsid proteins in the nucleus . Like UL43, UL43.5 is also dispensable for viral replication in cell culture. However, in PrV there is no indication of expression of an UL43.5-like open reading frame antisense to UL43 (Klupp et al., 2004; Powers et al., 1994) .
Despite its non-essential character the conservation of UL43 homologs within the alpha-and gammaherpesviruses is striking. Apparently, their role is either limited to certain aspects of the viral life cycle as may be the case for the EBV BMRF2 protein (Tugizov et al., 2003) , or their function is redundant and also executed by other viral proteins. We analyzed a possible redundancy of function following the observation that the UL43 protein inhibits membrane fusion in a transient expression-fusion system involving PrV envelope glycoproteins. Coexpression of UL43 reduces fusion to a similar extent as coexpression of gM (Klupp et al., 2000a; this paper) . In the case of gM, this fusion inhibition correlates with retention of fusogenic viral envelope proteins in the Golgi apparatus (Crump et al., 2004) . Moreover, we show that fusion is also inhibited by coexpression of gK and UL20 as has recently been demonstrated for the homologous HSV-1 proteins (Avitabile et al., 2004) . Since gM and gK also represent multiply membrane spanning proteins like the UL43 protein, it is possible that their roles are related. However, characterization of mutant viruses lacking UL43 and either gM or gK yielded no phenotype indicative of synergy or redundancy. A mutant lacking all three of these proteins has not yet been constructed. Thus, it is still possible that the three proteins share an important function which can still be executed even in the absence of two of them.
Interestingly, the UL43 protein was found in infected and transfected cells in vesicular structures in the cytoplasm. A similar subcellular localization has previously been observed for gB, and we show here that the two proteins indeed colocalize. Whether this reflects a physical and/or functional interaction is unclear at present. gB is an essential part of the fusion complex which is required for penetration and for direct viral cell-to-cell spread (Spear and Longnecker, 2003) . It is endocytosed via signals contained in the intracytoplasmic carboxy-terminal part of the protein (Nixdorf et al., 2000; Van Minnebruggen et al., 2004) . Mutation of these endocytosis signals results in a higher density of gB at the plasma membrane and increased cell-cell fusion (Nixdorf et al., 2000; Van Minnebruggen et al., 2004) . We did not observe any striking effect of the deletion of UL43 on fusion processes during virus infection, although, as discussed above, this could be due to functional redundancy with other viral proteins. Thus, the observed colocalization may indeed be functionally relevant.
In summary, we identified the PrV UL43 protein and showed that it is a virion constituent. Although deletion of UL43 from the viral genome did not result in a robust phenotype, in transient expression assays the UL43 protein strongly inhibited membrane fusion induced by the viral fusion machinery to a similar extent as gM. Thus, it is conceivable that the PrV UL43 protein is involved in modulating fusion processes during infection.
Materials and methods
Viruses and cells
All viruses used in this study were derived from PrV strain Kaplan (PrV-Ka; Kaplan and Vatter, 1959) . Construction of virus mutants lacking genes coding for glycoproteins gM and gK as well as generation of recombinant cell lines constitutively expressing gM or gK have been described elsewhere (Dietz et al., 2000; Dijkstra et al., 1997) . Viruses were propagated on rabbit kidney cells (RK13), genetically engineered RK13 cells expressing viral proteins, or porcine kidney cells (PSEK) in minimum essential medium supplemented with 10% or 5% fetal calf serum, respectively. Construction of mutants lacking UL43, UL43 and gM, or UL43 and gK is described below. An RK13 cell line which constitutively expresses UL43 was isolated after transfection of RK13 cells with pcDNA-UL43. In this plasmid, the PCR amplified UL43 open reading frame was cloned under control of the immediate-early promotor-enhancer complex of human cytomegalovirus. To this end, PCR was performed using primers UL43For1 (5V -CACAGAATTCCGCCGTCGCGATGATCTCC-3V , nt 52832-52850; GenBank Accession No. BK001744; Klupp et al., 2004) and UL43Rev1 (5V -CACATCTAGAGAG-CGTGGGCGTGAATCAGG-3V , nt 53978-53959; Accession No. BK001744), pfx DNA polymerase (Invitrogen, Karlsruhe, Germany), and cloned BamHI-fragment 2 (see Fig.  1B ) as template. The 1166-bp PCR product was digested with EcoRI and XbaI using restriction sites introduced with the primers (underlined), and cloned into appropriately cleaved eukaryotic expression vector pcDNA3 (Invitrogen) giving rise to plasmid pcDNA-UL43. UL43 start and stop codons are shown in bold. Transfected cells were selected with medium containing 0.5 mg G418 (Invitrogen) per ml, and resistant cell clones were tested with the anti-UL43 serum (see below) in indirect immunofluorescence and Western blotting (data not shown). One cell clone was selected for further experiments and designated RK13-UL43.
Construction of UL43 mutants
For deletion of the PrV UL43 open reading frame a 2.7kb PstI/KpnI subfragment of BamHI-fragment 2 (Fig. 1B) was cloned into pUC19 (New England Biolabs, Frankfurt, Germany) resulting in plasmid pPK2.7. This plasmid was digested with XhoI thereby deleting codons 23-332 of the 373 aa UL43 open reading frame generating plasmid pPK2.7DXhoI. Into the reconstituted XhoI site a GFP expression cassette was inserted. The resulting plasmid pDUL43gfp and PrV-Ka DNA were used for cotransfection into RK13 cells using calcium phosphate coprecipitation (Graham and van der Eb, 1973) . Transfection progeny was screened for green fluorescing plaques, which were purified to homogeneity resulting in the isolation of PrV-DUL43G. To delete the introduced heterologous GFP gene, genomic DNA of PrV-DUL43G was cotransfected with plasmid pPK2.7DXhoI, and transfection progeny was screened for non-fluorescing plaques. One plaque isolate was designated PrV-DUL43 and used for further studies. In this mutant, the 23 5V -terminal codons are retained and fused out-of-frame to the 40 3V -terminal codons, which theoretically could result in a fusion protein containing the amino terminal 23 aa of UL43 and 18 non-UL43 Cterminal amino acids.
To isolate a mutant simultaneously lacking UL43 and gM genomic DNA of PrV-DUL43 was cotransfected with plasmid pDUL10h (Dijkstra et al., 1997) into RK13-gM cells (Brack et al., 1999) and screened for blue plaques. One plaque isolate, designated PrV-DUL43/Mh, was further characterized. A mutant simultaneously lacking UL43 and gK was isolated after cotransfection of PrV-DgKw viral DNA and plasmid pDUL43gfp into RK13-gK cells (Dietz et al., 2000) followed by purification of green fluorescing plaques. The resulting double mutant was named PrV-DgK/ UL43G. DNA of all recombinants was analyzed by Southern blot hybridizations to verify correct deletion of genomic sequences and insertion of marker genes.
Preparation of antiserum
The PrV UL43 gene product is predicted to possess multiple membrane spanning domains (Powers et al., 1994) . To generate an antiserum against PrV UL43 part of the protein predicted to be hydrophilic and not embedded in a membrane was expressed as GST-fusion protein in Escherichia coli (Fig. 1A) . To this end, DNA encoding aa 147-231 was PCR-amplified using primers UL43For2 (5V -CACA-GAATTCGGGCCCTCGTGAACGTGCG-3V ; nt 53278-53296; Accession No. BK001744) and UL43Rev2 (5V -CACACTCGAGCTGCCGGCGTAGGCGTGG-3V ; nt 53534-53516, Accession No. BK001744) and pfx DNA polymerase (Invitrogen) using cloned BamHI-fragment 2 as template. The resulting 275 bp PCR product was digested with EcoRI and XhoI using the artificially introduced restriction sites (underlined) and cloned into appropriately cleaved prokaryotic expression vector pGEX-4T-2. The 35-kDa GST-UL43 147-231 fusion protein was purified and used for immunization of a rabbit as described .
Indirect immunofluorescence and confocal laser scan microscopy
RK13 cells grown on cover slips were infected with PrV-Ka or PrV-DUL43 at an MOI of 10, or transfected with expression plasmids for UL43 and gB. Four hours after infection or 48 h after transfection they were fixed for 20 min with 3% paraformaldehyde (PFA) followed by 10 min incubation with 3% PFA with 0.3% Triton X-100. The fixed cells were subsequently incubated with monospecific antiserum against UL43 and/or monoclonal antibodies against gB (Nixdorf et al., 2000) or gC for 1 h at room temperature followed by Alexa 488-conjugated anti-rabbit and/or Alexa 594conjugated anti-mouse secondary antibodies (Molecular Probes, Leiden, The Netherlands). Fluorescence was preserved with a 9:1 mixture of glycerol and PBS containing 2.5 mg 1,4-diazabicyclooctane per ml. The slides were analyzed with a confocal laser scan microscope (LSM510; Zeiss, Gfttingen, Germany).
Virus purification and immunoblotting
Virus purification and preparation of infected cell lysates was performed as described (Kopp et al., 2003) . Parallel blots were incubated with monospecific antisera against UL43 (this study), gM (Kopp et al., 2003) , gK (D4-1; Dietz et al., 2000) , UL37 , gH , and UL34 (Klupp et al., 2000b) , or monoclonal antibodies against gB (b43-b5; Nixdorf et al., 2000) and gC (B16-c8; Klupp and Mettenleiter, 1999) . For detection of the highly hydrophobic gK, gM, and UL43 proteins, gels were blotted onto PVDF membranes (Immobilon P, Millipore, Eschborn, Germany).
One-step growth and plaque assays
One-step growth analyses were performed as described previously ). Wild-type or comple-menting RK13 cells were harvested 0, 4, 8, 12, 24, or 36 h after infection at an MOI of 5. Progeny virus titers were determined on RK13 cells. The mean titers and corresponding standard deviation of three independent experiments were plotted. For determination of plaque sizes cells were infected at a low MOI and incubated under a methylcellulose overlay for 2 days. Infected cells were fixed with 2.5% formaldehyde and stained with 1% crystal violet in 50% ethanol. Plaques were measured microscopically, and mean diameters including standard deviation of three independent experiments were calculated.
Fusion assay
Fusion assays were performed as described previously (Klupp et al., 2000a,b) using expression plasmids for a C-terminally truncated gB protein, gB-008 (Nixdorf et al., 2000) , and gDH, a hybrid protein consisting of the Nterminal 271 amino acids of gD fused to the 590 Cterminal amino acids of gH . This two-component fusion system exhibits greater fusion activity than obtained with the wild-type proteins gB, gH, and gL. The two expression plasmids were cotransfected as indicated with empty vector pcDNA3, or expression vectors for gM (Klupp et al., 2000a ,b), gN (Jöns et al., 1998 , UL20 (Dietz et al., 2000) , gK (Dietz et al., 2000) , and UL43 (this study). 750 ng of each plasmid was used for the assay. Transfected cells were incubated for 40 h at 37 8C. They were then fixed with 80% ethanol and incubated with a monoclonal antibody against gB (A20-c26; Nixdorf et al., 2000) followed by Alexa 488-conjugated anti-mouse IgG (Molecular Probes).
For quantification of the fusion assays random digital photographs of the immunostained cells were taken using a C3040Zoom camera (Olympus, Hamburg, Germany) mounted on an inverted microscope IX50 (Olympus) at a magnification of 100. In each assay the area of 50 polykaryocytes of more than 2 nuclei was determined using the measurement function of the DP-Soft (Version 3.2) software (Olympus). A maximum of 25 syncytia per picture were measured starting with the largest object. Three independent assays were performed and the result of each assay was calculated compared to the fusion activity of gB-008 and gDH which was set as 100%. Mean values and standard deviation are given.
